These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29436051)

  • 1. Alum-adjuvanted allergoids induce functional IgE-blocking antibodies.
    Reithofer M; Böll SL; Kitzmüller C; Horak F; Sotoudeh M; Bohle B; Jahn-Schmid B
    Clin Exp Allergy; 2018 Jun; 48(6):741-744. PubMed ID: 29436051
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant effects of aluminium hydroxide-adsorbed allergens and allergoids - differences in vivo and in vitro.
    Heydenreich B; Bellinghausen I; Lund L; Henmar H; Lund G; Adler Würtzen P; Saloga J
    Clin Exp Immunol; 2014 Jun; 176(3):310-9. PubMed ID: 24528247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depigmented allergoids reveal new epitopes with capacity to induce IgG blocking antibodies.
    López-Matas MA; Gallego M; Iraola V; Robinson D; Carnés J
    Biomed Res Int; 2013; 2013():284615. PubMed ID: 24222901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy.
    van Neerven RJ; Knol EF; Ejrnaes A; Würtzen PA
    Int Arch Allergy Immunol; 2006; 141(2):119-29. PubMed ID: 16864979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination for birch pollen allergy: comparison of the affinities of specific immunoglobulins E, G1 and G4 measured by surface plasmon resonance.
    Jakobsen CG; Bodtger U; Poulsen LK; Roggen EL
    Clin Exp Allergy; 2005 Feb; 35(2):193-8. PubMed ID: 15725191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of a residual group in low-molecular-weight allergoids of Artemisia vulgaris pollen on their allergenicity, IgE- and IgG-binding properties.
    Cirković T; Gavrović-Jankulović M; Prisić S; Jankov RM; Burazer L; Vucković O; Sporcić Z; Paranos S
    Allergy; 2002 Nov; 57(11):1013-20. PubMed ID: 12358997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-based assays for potency determination of mite allergoids and for stability studies of alum-adsorbed mite vaccines.
    Kerkvliet E; Sinnige N; Franso C; van Ree R; van den Hout R
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2013; 97():106-11. PubMed ID: 24912321
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of 'blocking' IgG antibodies during immunotherapy.
    Wachholz PA; Durham SR
    Clin Exp Allergy; 2003 Sep; 33(9):1171-4. PubMed ID: 12956735
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immune response in therapy with allergens and allergoids].
    Kalveram CM; Kalveram KJ; Kästner H; Forck G
    Z Hautkr; 1986 Feb; 61(3):118-23. PubMed ID: 3953134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced desensitization efficacy by liposomal conjugation of a specific antigen.
    Ichikawa K; Urakami T; Yonezawa S; Miyauchi H; Shimizu K; Asai T; Oku N
    Int J Pharm; 2007 May; 336(2):391-5. PubMed ID: 17234372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peanut oral immunotherapy induces blocking antibodies but does not change the functional characteristics of peanut-specific IgE.
    Santos AF; James LK; Kwok M; McKendry RT; Anagnostou K; Clark AT; Lack G
    J Allergy Clin Immunol; 2020 Jan; 145(1):440-443.e5. PubMed ID: 31676085
    [No Abstract]   [Full Text] [Related]  

  • 12. Blocking antibodies in allergen immunotherapy: the Yin and Yang.
    Hardy CL; Rolland JM; O'Hehir RE
    Clin Exp Allergy; 2004 Apr; 34(4):510-2. PubMed ID: 15080798
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1.
    Sirvent S; Soria I; Cirauqui C; Cases B; Manzano AI; Diez-Rivero CM; Reche PA; López-Relaño J; Martínez-Naves E; Cañada FJ; Jiménez-Barbero J; Subiza J; Casanovas M; Fernández-Caldas E; Subiza JL; Palomares O
    J Allergy Clin Immunol; 2016 Aug; 138(2):558-567.e11. PubMed ID: 27177779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of a common regulation of IgE and IgG-subclass antibodies in humans during immunotherapy.
    Søndergaard I; Poulsen LK; Osterballe O; Weeke B
    Allergy; 1992 Oct; 47(5):467-70. PubMed ID: 1485649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children.
    Zhao D; Lai X; Tian M; Jiang Y; Zheng Y; Gjesing B; Zhong N; Spangfort MD
    Int Arch Allergy Immunol; 2016; 169(2):113-20. PubMed ID: 27049773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of allergoids from ovalbumin in vitro and in vivo.
    Salgado J; Casadevall G; Puigneró V; Queralt J
    Immunobiology; 1996; 196(4):375-86. PubMed ID: 9061378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic responses to sublingual allergen immunotherapy.
    Akdis M
    Clin Allergy Immunol; 2008; 21():71-86. PubMed ID: 18828499
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyposensitization: indications and expectations].
    Urbanek R
    Padiatr Padol; 1990; 25(6):397-404. PubMed ID: 2080061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergoids for Allergy Treatment.
    Carnes J; Gallego MT; Moya R; Iraola V
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):110-119. PubMed ID: 29473530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.